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Abstract
Objective: To investigate the association between Obsessive-Compulsive Disorder (OCD) and 
a functional polymorphism of MCP-1 in the Chinese Han population. Method: We genotyped 
and performed a case-control association analysis of the MCP-1 -2518G/A polymorphism in 200 
OCD patients and 294 healthy control subjects. Results
2 = 1.123, 
2 = 0.802, df = 1, P = 0.37 by allele). Conclusions: Our results 
indicated that MCP-1 -2518G/A may not play a major role in the genetic predisposition of the 
Chinese Han population to OCD. However, further studies using a larger number of subjects 
are required to obtain a clear conclusion.
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Estudo de associação de casos-controle entre Transtorno Obsessivo-Compulsivo (TOC) 
Resumo
Objetivo:
funcional de MCP-1 na população chinesa de etnia Han. Métodos: Determinamos os genótipos 
em 200 indivíduos com TOC e 294 indivíduos saudáveis (controle). Resultados: Não houve 
2 2 = 0,802, df = 1, P = 0,37 por alelo). 
Conclusões: Nossos resultados indicaram que MCP-1 -2518G/A pode não ter grande participação 
um maior número de indivíduos são necessários para uma conclusão mais clara.
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Introduction
Obsessive-Compulsive Disorder (OCD) is a mental disorder 
characterized by repetitive, obsessive thinking and com-
pulsive behavior. Its lifetime prevalence is 1.9–3.3%,1 which 
makes OCD the fourth most common mental disorder behind 
phobias, substance dependence, and major depression. 
In the last several years, a number of studies have found 
and T-cell function.2-3 
Mainly derived from perivascular astrocytes, monocyte 
chemoattractant protein I (MCP-1) increases blood brain 
barrier (BBB) permeability and attracts leukocytes across 
the BBB, which possibly draws autoantibodies in the serum 
of OCD patients to the basal ganglia.4 When associated with 
the BBB endothelium, MCP-1 plays a role in mediating: 
1.) the differentiation of neural stem cells into neurons, 
astrocytes and oligodendrocytes and 2.) the regulation of 
adult subventricular zone-derived progenitor cell migration 
after striatal cell death.5 Together, these roles indicate 
an intimate association between neurodevelopmental and 
mediators. The MCP-1 -2518G/A polymorphism may affect 
the transcriptional activity of monocyte MCP-1 production 
6
We hypothesized that MCP-1 might increase the risk of 
OCD. We performed an association study between OCD and 
the 2518G/A polymorphism of MCP-1 to examine the hypoth-
of OCD in a Chinese Han population.
Materials and Methods
Study Population
A total of 200 OCD patients [mean age = 28.92 years and 
SD = 10.85 years; 35.6% females; 64.4% males mean age of 
onset = 19.75 years and SD = 10.72 years; 25.4% early onset 
(< 17 years old); mean duration of the disorder = 10.84 
years and SD = 8.65 years] and 294 healthy control subjects 
[mean age = 30.52 years and SD = 9.65 years; 34.8% females; 
Medical College, Qingdao University. All of the patients were 
diagnosed according to DSM-IV diagnostic criteria. Probands 
with a history of neurologic or metabolic diseases, bipolar or 
psychotic disorder, or current substance dependence were 
excluded. Control subjects were selected from among healthy 
volunteers from Qingdao University, and all had no history of 
any psychiatric disorder. The Ethics Committees of Qingdao 
University Medical College Hospital approved the study, and 
all of the subjects provided written informed consent.
DNA analysis and statistical analysis
Genomic DNA was extracted from peripheral blood leukocytes 
using standard methods. The polymorphism at 2518G/A in 
the promoter region of MCP-1 was genotyped by polymerase 
chain reaction-restriction fragment length polymorphism 
(PCR-RFLP) according to the procedure described by 
Kuroda et al.7 The sequences of several PCR products were 
-
formed using the chi-square test of homogeneity. 
Results
According to Hardy-Weinberg equilibrium, the genotypic 
-
2 = 0.056 with 1 df and 
2 = 0.413 with 1 df and P = 0.52). 
and allelic frequencies between OCD cases and controls 
2 2 = 0.802, df = 1, 
P = 0.37 by allele) (Table 1).
Discussion
A number of studies have demonstrated a connection between 
OCD and infections, thus indicating the existence of possible 
immune dysfunction in OCD.8 Consequently, many interesting 
-
matory factors, warrant investigation, and a series of studies 
has already been performed. Unfortunately, the results of 
these studies were quite inconsistent. Konuk and colleagues 
453A case-control association study between OCD and the MCP-1 -2518G/A polymorphism
and IL-6 in OCD patients compared with healthy controls.9 As 
mentioned above, MCP-1 is a critical chemokine that is closely 
-
the brain.10 We hypothesized that MCP-1 could increase the 
risk of OCD, but there has been no evidence supporting our 
nucleotide polymorphism in MCP-1 in relation to OCD. Our 
-
typic and allelic frequencies between 200 OCD cases and 294 
controls. It is unlikely that this result is due to quality control 
issues as the experiment was carefully designed, we used 
proper equipment that had a high accuracy, and the sequences 
The patient and control samples were chosen carefully and 
randomly, and those individuals who had mental disabilities, 
drug and/or alcohol dependence, or metabolic, psychiatric, or 
neurological diseases were excluded. The genetic background 
of the sample was also strictly considered. However, the fol-
lowing reasons could explain our negative results. The most 
likely reason is low power due to limited sample size (only 
14.8%). Additionally, MCP-1 could play only a minor role, thus 
contributing only a small increase in risk that could be unde-
tectable due to the small sample size. Moreover, the onset age 
of OCD and the rate of patients with an earlier onset of OCD 
could not be excluded. Therefore, further research targeting 
other populations should be performed, which would provide 
a better understanding of MCP-1 expression functionality.
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Controls 294 97 (0.330) 139 (0.473) 58 (0.197) 333 (56.6) 255 (43.4)
